Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA

Liang Shi1, Qinghong Xin2, Ruonan Chai3

  • 1Department of Respiratory Disease, Chinese PLA General Hospital Beijing 100853, China.

Insights

MicroRNAs (miRNAs) play a role in chronic obstructive pulmonary disease (COPD). This study found miR-203 targets TAK1 and PIK3CA, suggesting its role in COPD pathogenesis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pulmonology

Background:

  • MicroRNAs (miRNAs) are short non-coding RNAs regulating gene expression.
  • Altered miRNA profiles are observed in chronic obstructive pulmonary disease (COPD) patients.
  • The precise mechanisms of miRNA involvement in COPD remain unclear.

Purpose of the Study:

  • Investigate miRNA expression in COPD lung and blood samples.
  • Identify specific miRNAs and their targets involved in COPD.
  • Elucidate the role of miR-203 in regulating inflammatory pathways in COPD.

Main Methods:

  • miRNA expression profiling in lung and blood samples from COPD patients, smokers, and controls.
  • Bioinformatic prediction, luciferase assays, and Western blot to identify miRNA targets.
  • Analysis of NF-κB signaling pathway components (p-IκBα, p-p65) and inflammatory cytokines (TNF-α, IL-6) in epithelial cells.

Main Results:

  • Expression of miR-181a, miR-203, miR-338, miR-1, and miR-199a was altered in COPD lung samples.
  • miR-203 expression was significantly higher in blood of smokers and COPD patients.
  • TAK1 and PIK3CA were confirmed as direct targets of miR-203.
  • COPD epithelial cells showed lower p-IκBα and p-p65 levels upon LPS stimulation.
  • miR-203 overexpression in control cells repressed NF-κB signaling.

Conclusions:

  • miR-203 directly targets TAK1 and PIK3CA, key regulators of the NF-κB pathway.
  • Downregulation of miR-203 may contribute to COPD pathogenesis by promoting inflammation.
  • miR-203 represents a potential therapeutic target for COPD.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K